2021/12/23
Clinical Development Updates on Medigen's MVC-COV1901 in COVID-19 Solidarity Trial Vaccines
2021/12/02
CEPI and MVC co-fund mix-and-match booster trial of COVID-19 vaccines
2021/11/22
Medigen is Granted Provisional Determination by Australia's Therapeutic Goods Administration (TGA)
2021/11/11
Clinical Development Updates on Medigen's MVC-COV1901 in COVID-19 Solidarity Trial Vaccines
2021/10/27
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
2021/10/15
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree